Evidence map›Paper›PMID 39692115›Full record

ArticleJournal of extracellular vesicles2024

EV-Elute: A universal platform for the enrichment of functional surface marker-defined extracellular vesicle subpopulations.

Willemijn S de Voogt, Rowan Frunt, Raul M Leandro, Casper S Triesscheijn, Bella Monica, Ioanna Paspali, Mark Tielemans, Jerney J J M François, Cor W Seinen, Olivier G de Jong and 1 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Basic Guide for Approaching Drug Delivery with Extracellular Vesicles.International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Willemijn S de VoogtCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0009-0008-7876-5018
Rowan FruntCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-8283-273X
Raul M LeandroCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Casper S TriesscheijnCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Bella MonicaCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Ioanna PaspaliCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Mark TielemansCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Jerney J J M FrançoisCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Cor W SeinenCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.
Olivier G de JongDepartment of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-5952-9617
Sander A A KooijmansCDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0002-8893-9578

Funding

Dutch Research Council (NWO), Domain Applied and Engineering Sciences 17296
6 · The paper itself

Abstract

Intercellular communication via extracellular vesicles (EVs) has been identified as a vital component of a steadily expanding number of physiological and pathological processes. To accommodate these roles, EVs have highly heterogeneous molecular compositions. Given that surface molecules on EVs determine their interactions with their environment, EV functionality likely differs between subpopulations with varying surface compositions. However, it has been technically challenging to examine such functional heterogeneity due to a lack of non-destructive methods to separate EV subpopulations based on their surface markers. Here, we used the Design-of-Experiments (DoE) methodology to optimize a protocol, which we name 'EV-Elute', to elute intact EVs from commercially available Protein G-coated magnetic beads. We captured EVs from various cell types on these beads using antibodies against CD9, CD63, CD81 and a custom-made protein binding phosphatidylserine (PS). When applying EV-Elute, over 70% of bound EVs could be recovered from the beads in a pH- and incubation-time-dependent fashion. EV subpopulations showed intact integrity by electron microscopy and Proteinase K protection assays and showed uptake patterns similar to whole EV isolates in co-cultures of peripheral blood mononuclear cells (PBMCs) and endothelial cells. However, in Cas9/sgRNA delivery assays, CD63

Indexed as

BiomarkersExtracellular VesiclesHumansLeukocytes, MononuclearTetraspanin 28Tetraspanin 29BiomarkersTetraspanin 28Tetraspanin 29CRISPR/Cas9extracellular vesiclesextracellular vesicle subpopulationsheterogeneityimmunoprecipitation

Identifiers

PMID39692115
PMCPMC11653091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.